• Opera Limited recently reported past earnings for the second quarter and first half of 2026, with Q2 sales of US$178.07 million and net income of US$27.55 million, alongside higher basic and diluted earnings per share from continuing operations than a year earlier.
• Across the first six months, Opera’s rising sales to US$353.84 million and net income of US$52.34 million highlight improving profitability from its ongoing operations.
• We will now examine how Opera’s higher earnings per share from continuing operations shapes the company’s investment narrative and future positioning.

AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

What Is Opera's Investment Narrative?

For Opera to make sense in a portfolio, you need to believe its browser, MiniPay ecosystem and AI products can keep pulling in more users and monetization, while management continues returning cash via dividends and buybacks. The latest Q2 numbers, with higher earnings per share from continuing operations, broadly support that thesis and align with earlier guidance, so they seem more like confirmation than a big reset of the story. Near term, the key catalysts still look tied to execution on MiniPay, the Visa-backed MiniPay Card rollout, and further AI adoption within its browsers, with these results giving Opera a bit more financial flexibility to keep investing. On the risk side, a relatively new management team, low board independence and reliance on a few high-growth initiatives remain important pressure points that Q2’s strength does not fully address.

However, one governance concern here is something investors should not overlook. Despite retreating, Opera's shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

Seven Simply Wall St Community fair value views span roughly US$23 to just over US$61 per share, showing how far apart private investors can be. When you set that against Opera’s recent earnings momentum and ongoing governance concerns, it underlines why comparing multiple viewpoints before committing capital really matters.

Explore 7 other fair value estimates on Opera - why the stock might be worth just $23.00!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Opera research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Opera research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Opera's overall financial health at a glance.

Want Some Alternatives?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.